Updates on managing advanced breast cancer with palbociclib combination therapy

BACKGROUND: The objective of this study was to review the pharmacology, efficacy, and safety of palbociclib, a first-in-class cyclin-dependent kinase 4/6 inhibitor, for the management of advanced breast cancer (ABC). METHODS: Pharmacokinetics and drug interactions associated with palbociclib are des...

Descripción completa

Detalles Bibliográficos
Autores principales: McShane, Teresa M., Wolfe, Thomas A., Ryan, Joanne C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122240/
https://www.ncbi.nlm.nih.gov/pubmed/30202448
http://dx.doi.org/10.1177/1758835918793849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122240/
https://www.ncbi.nlm.nih.gov/pubmed/30202448
http://dx.doi.org/10.1177/1758835918793849

Ejemplares similares